Correlation analysis clearly indicates that higher expression of RASSF10 and NPM correlates with better patient survival (Fig. 6C); in contrast, higher expression of RNF2 correlated with poor survival of patients with gastric cancer (Fig. 6C). This evidence concerns the gene RASSF10 and gastric cancer.